News & Updates

Guselkumab resolves enthesitis in most PsA patients

28 Apr 2021 by

Treatment with the selective interleukin-23 inhibitor guselkumab results in the clearance of enthesitis for many psoriatic arthritis (PsA) patients, with the resolution maintained through month 12, as shown by pooled data from two phase III trials.

Guselkumab resolves enthesitis in most PsA patients

28 Apr 2021

What is the standard antiplatelet regimen in neuro-endovascular patients?

28 Apr 2021

A survey of neuro-endovascular centres in the US has found dual antiplatelet therapy with aspirin and clopidogrel to be the standard of care in patients undergoing endovascular neuro-interventional procedures. Nearly half of responding institutions use ticagrelor if clopidogrel resistance is suspected.

What is the standard antiplatelet regimen in neuro-endovascular patients?

28 Apr 2021

Pharmacists approve of vancomycin AUC monitoring, cite improved safety outcomes

28 Apr 2021

Pharmacists have seen improvements in safety outcomes following the change to vancomycin area under the curve (AUC) therapeutic drug monitoring, according to a study. Efficacy, on the other hand, appears similar if not increased.

Pharmacists approve of vancomycin AUC monitoring, cite improved safety outcomes

28 Apr 2021

Statin strikes out in knee osteoarthritis

28 Apr 2021

In patients with symptomatic knee osteoarthritis, treatment with atorvastatin falls short of reducing cartilage volume loss over 2 years as compared with placebo, according to the results of a trial.

Statin strikes out in knee osteoarthritis

28 Apr 2021

Menopausal hormone therapy may be protective against colorectal cancer

28 Apr 2021

Women exposed to menopausal hormone therapy, including oestrogen‐only preparations and oestrogen combined progestin therapy, appear to have a lower risk of colorectal adenocarcinoma, a study has found.

Menopausal hormone therapy may be protective against colorectal cancer

28 Apr 2021

High infliximab exposure needed for radiologic remission in Crohn’s disease

27 Apr 2021 by

Patients with active luminal Crohn’s disease are likely to achieve radiologic response and remission with infliximab trough level of 7.8 µg/ml at the end of induction therapy, as indicated by data from the TAILORIX trial.

High infliximab exposure needed for radiologic remission in Crohn’s disease

27 Apr 2021

DPP-4i plus insulin on par with other regimens for glucose control after cardiac surgery

27 Apr 2021

Glucose control among postoperative cardiac surgery patients with prediabetes or diabetes receiving dipeptidyl peptidase-4 inhibitors (DPP-4i) plus basal insulin is similar to those on other regimens, a study has shown. In addition, use of DPP-4i does not result in hypoglycaemia.

DPP-4i plus insulin on par with other regimens for glucose control after cardiac surgery

27 Apr 2021

BIO89-100 reduces liver fat in NASH

27 Apr 2021 by

Weekly (QW) or biweekly (Q2W) treatment with BIO89-100 led to a significantly reduced liver fat and liver fat volume (LFV) in patients with nonalcoholic steatohepatitis (NASH), according to a recent study presented at ENDO 2021.

BIO89-100 reduces liver fat in NASH

27 Apr 2021

IL-17 inhibitor takes on axial spondyloarthritis in Asians

26 Apr 2021 by

Interleukin (IL)-17 inhibition with brodalumab has demonstrated therapeutic potential for Asian patients with active axial spondyloarthritis in a phase III trial.

IL-17 inhibitor takes on axial spondyloarthritis in Asians

26 Apr 2021

Cold plus flu medications therapy does not improve OSA severity

26 Apr 2021

Combination treatment with pseudoephedrine and diphenhydramine has failed to improve obstructive sleep apnoea (OSA) severity or genioglossus responsiveness in a recent study, but it has led to a slight improvement in upper airway collapsibility, possibly due to the decongesting effect of the medications.

Cold plus flu medications therapy does not improve OSA severity

26 Apr 2021

News & Updates

Filter by Specialty:

Specialty:

Guselkumab resolves enthesitis in most PsA patients

Guselkumab resolves enthesitis in most PsA patients

What is the standard antiplatelet regimen in neuro-endovascular patients?

What is the standard antiplatelet regimen in neuro-endovascular patients?

Pharmacists approve of vancomycin AUC monitoring, cite improved safety outcomes

Pharmacists approve of vancomycin AUC monitoring, cite improved safety outcomes

Statin strikes out in knee osteoarthritis

Statin strikes out in knee osteoarthritis

Menopausal hormone therapy may be protective against colorectal cancer

Menopausal hormone therapy may be protective against colorectal cancer

High infliximab exposure needed for radiologic remission in Crohn’s disease

High infliximab exposure needed for radiologic remission in Crohn’s disease

DPP-4i plus insulin on par with other regimens for glucose control after cardiac surgery

DPP-4i plus insulin on par with other regimens for glucose control after cardiac surgery

BIO89-100 reduces liver fat in NASH

BIO89-100 reduces liver fat in NASH

IL-17 inhibitor takes on axial spondyloarthritis in Asians

IL-17 inhibitor takes on axial spondyloarthritis in Asians

Cold plus flu medications therapy does not improve OSA severity

Cold plus flu medications therapy does not improve OSA severity